Which pioneering medical product launch was the first FDA-approved gene therapy for a genetic disease in the United States?

The healthcare industry has seen remarkable product innovations that have revolutionized patient care and treatment outcomes. This poll tests your knowledge about a significant pharmaceutical product launch that changed the landscape of medical treatment. Consider how this innovation impacted healthcare delivery and patient outcomes while reflecting on the regulatory challenges faced during its development and release.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Luxturna (voretigene neparvovec) for inherited retinal disease in 2017
Zolgensma (onasemnogene abeparvovec) for spinal muscular atrophy in 2019
Kymriah (tisagenlecleucel) for B-cell acute lymphoblastic leukemia in 2018
Yescarta (axicabtagene ciloleucel) for large B-cell lymphoma in 2020